Director of Clinical Bioanalysis
Daiichi Sankyo
Cranbury, New Jersey, United States
Dr. Xiaohui (Sophia) Xu is the Director of Clinical Bioanalysis at Daiichi-Sankyo Inc. She is actively serving in the AAPS PK Assay Group, AAPS Reagent Team, AAPS Award Committee. She also serves in IQ Consortium Metabolite Bbioanalysis Working Group. Dr. Xu has extensive experiences in regulated bioanalytical field in cluding from post IND to global submissions and life cycle management, covering small molecules, biologics, new modalities. She has extensive publications and oral presentations as invited speakers. She also authored 2 book chapters and co-edited one book entitled "Bioanalytical Aspects of Biologics by Wiley". In the past, She also served AAPS session chair, CPSA steering committee and session chair, EAS session chair. She received her Ph.D. in Pharmaceutical Analysis from College of Pharmacym the Univeristy of Georgia.
Disclosure information not submitted.
Wednesday, April 26, 2023
12:30 PM – 1:30 PM ET